LYVE1 and esophageal adenocarcinoma: In contrast, using LYVE-1 as a marker for lymphatic vessels, Brundler et al. observed no significant correlation between LVD and clinical outcome and concluded that LVD had no prognostic value in esophageal adenocarcinoma [20].